These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 11090155

  • 1. Functional mapping of protective domains and epitopes in the rotavirus VP6 protein.
    Choi AH, Basu M, McNeal MM, Flint J, VanCott JL, Clements JD, Ward RL.
    J Virol; 2000 Dec; 74(24):11574-80. PubMed ID: 11090155
    [Abstract] [Full Text] [Related]

  • 2. Functional mapping of protective epitopes within the rotavirus VP6 protein in mice belonging to different haplotypes.
    Choi AH, McNeal MM, Basu M, Bean JA, VanCott JL, Clements JD, Ward RL.
    Vaccine; 2003 Jan 30; 21(7-8):761-7. PubMed ID: 12531356
    [Abstract] [Full Text] [Related]

  • 3. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.
    Choi AH, Basu M, McNeal MM, Clements JD, Ward RL.
    J Virol; 1999 Sep 30; 73(9):7574-81. PubMed ID: 10438847
    [Abstract] [Full Text] [Related]

  • 4. Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses.
    Choi AH, McNeal MM, Basu M, Flint JA, Stone SC, Clements JD, Bean JA, Poe SA, VanCott JL, Ward RL.
    Vaccine; 2002 Sep 10; 20(27-28):3310-21. PubMed ID: 12213401
    [Abstract] [Full Text] [Related]

  • 5. Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G).
    Smiley KL, McNeal MM, Basu M, Choi AH, Clements JD, Ward RL.
    J Virol; 2007 Apr 10; 81(8):3740-8. PubMed ID: 17251301
    [Abstract] [Full Text] [Related]

  • 6. The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant.
    Choi AH, McNeal MM, Flint JA, Basu M, Lycke NY, Clements JD, Bean JA, Davis HL, McCluskie MJ, VanCott JL, Ward RL.
    Vaccine; 2002 Mar 15; 20(13-14):1733-40. PubMed ID: 11906760
    [Abstract] [Full Text] [Related]

  • 7. CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G).
    McNeal MM, VanCott JL, Choi AH, Basu M, Flint JA, Stone SC, Clements JD, Ward RL.
    J Virol; 2002 Jan 15; 76(2):560-8. PubMed ID: 11752147
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice.
    Choi AH, Basu M, McNeal MM, Bean JA, Clements JD, Ward RL.
    Protein Expr Purif; 2004 Dec 15; 38(2):205-16. PubMed ID: 15555936
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates.
    VanCott JL, Prada AE, McNeal MM, Stone SC, Basu M, Huffer B, Smiley KL, Shao M, Bean JA, Clements JD, Choi AH, Ward RL.
    J Virol; 2006 May 15; 80(10):4949-61. PubMed ID: 16641286
    [Abstract] [Full Text] [Related]

  • 14. Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles.
    McNeal MM, Rae MN, Bean JA, Ward RL.
    J Virol; 1999 Sep 15; 73(9):7565-73. PubMed ID: 10438846
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. IFN-gamma is the only anti-rotavirus cytokine found after in vitro stimulation of memory CD4+ T cells from mice immunized with a chimeric VP6 protein.
    McNeal MM, Stone SC, Basu M, Clements JD, Choi AH, Ward RL.
    Viral Immunol; 2007 Dec 15; 20(4):571-84. PubMed ID: 18158731
    [Abstract] [Full Text] [Related]

  • 17. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
    Siadat-Pajouh M, Cai L.
    Viral Immunol; 2001 Dec 15; 14(1):31-47. PubMed ID: 11270595
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies.
    García-Díaz A, López-Andújar P, Rodríguez Díaz J, Montava R, Torres Barceló C, Ribes JM, Buesa J.
    Vaccine; 2004 Dec 09; 23(4):489-98. PubMed ID: 15530697
    [Abstract] [Full Text] [Related]

  • 20. VP6: A candidate rotavirus vaccine.
    Ward RL, McNeal MM.
    J Infect Dis; 2010 Sep 01; 202 Suppl():S101-7. PubMed ID: 20684688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.